Pnc Financial Services Group, Inc. Cure Vac N.V. Transaction History

Pnc Financial Services Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$13.18 - $19.41 $1,080 - $1,591	-82 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$14.73 - $35.25 $324 - $775	22 Added 36.67%	82 $1,000
Q4 2021 Feb 11, 2022	BUY	$33.72 - $48.22 $168 - $241	5 Added 9.09%	60 $2,000
Q2 2021 Aug 06, 2021	BUY	$56.91 - $127.53 $2,560 - $5,738	45 Added 450.0%	55 $4,000
Q4 2020 Feb 12, 2021	BUY	$46.76 - $136.27 $467 - $1,362	10 New	10 $0

107

21.1M

91.5K

145K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $990M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.